NATTOPHARMA ASA Revenue and Competitors
Estimated Revenue & Valuation
- NATTOPHARMA ASA's estimated annual revenue is currently $1.7M per year.
- NATTOPHARMA ASA's estimated revenue per employee is $155,000
Employee Data
- NATTOPHARMA ASA has 11 Employees.
- NATTOPHARMA ASA grew their employee count by -15% last year.
NATTOPHARMA ASA's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Director Sales | Reveal Email/Phone |
NATTOPHARMA ASA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $16.4M | 106 | 29% | N/A | N/A |
#2 | $1.7M | 11 | -15% | N/A | N/A |
#3 | $3.7M | 24 | 4% | N/A | N/A |
#4 | $3.1M | 20 | -66% | N/A | N/A |
#5 | $5.4M | 35 | 9% | N/A | N/A |
#6 | $7M | 45 | 2% | N/A | N/A |
#7 | $9.8M | 63 | -14% | N/A | N/A |
#8 | $8.5M | 55 | 28% | N/A | N/A |
What Is NATTOPHARMA ASA?
NattoPharma, the global Vitamin K2 R&D leader, continues to invest in true clinical science that further substantiates the bone and heart benefits of MenaQ7® Vitamin K2 as MK-7, the Expert Brand. The company delivers the most comprehensive K2 portfolio on the market, meeting manufacturers' and consumers' needs. • MenaQ7® Natural: chickpea-based fermentation • MenaQ7® PharmaPure: synthetic, natureidentical • MenaQ7® Natto: soy-based fermentation • MenaQ7®Full Spectrum: Holistic Vitamin K2 with MK-6, 7, 8 and 9 Further, NattoPharma helps manufacturers find the best solution for their Vitamin K2 applications, whether it be powder solutions, oils, water dispersible powders, liquid solutions, or the brand new CryoCap™, a microencapsulation technology that ensures MenaQ7® Vitamin K2 stability in even the most complex formulations. This solution-driven innovation ensures finished products deliver the proven benefits of MenaQ7® Vitamin K2, creating unparalleled value for brands and consumers. Backed by more than 19 published clinical trials, NattoPharma has the best clinically validated K2 on the market, and the only K2 with patents for cardiovascular health. NattoPharma: Our Science. Your Trust.
keywords:N/A
N/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
-15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NATTOPHARMA ASA News
With support from the Norwegian Research Council and a research grant awarded to NattoPharma ASA (now Gnosis by Lesaffre),...
Other Companies in Oslo
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 11 | -69% | N/A |
#2 | $2.2M | 12 | 0% | N/A |
#3 | $1.7M | 12 | -40% | N/A |
#4 | $1M | 12 | 9% | N/A |
#5 | $1.2M | 12 | 9% | N/A |